Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

First ERA-EDTA ‘CKD Anaemia Physician Bahaviours Survey' Reveals Complexities Of CKD Anaemia Management

22.06.2007
CKD Patients with Diabetes and Heart Disease Most Complex - Early Referral and Primary Care Education Needed

The European Renal Association-European Dialysis Transplant Association (ERA-EDTA) today announced results from the first ever Chronic Kidney Disease (CKD) Anaemia Physician Behaviours Survey, commissioned by ERA-EDTA and sponsored by an educational grant from Amgen. Nephrologists surveyed say that the majority of CKD anaemia patients (59.5 percent) also suffer from diabetes and heart disease. Three quarters of nephrologists (74 percent) describe these patients as complex to manage, suggesting a critical need for more proactive intervention.

The survey, conducted by independent research agency Harris Interactive, polled 369 nephrologists across five European countries (Germany, France, Italy, United Kingdom and Spain) in May and June 2007 to investigate unmet needs and real world challenges faced by physicians in managing CKD anaemia patients.

Alarming results show that nearly half of patients are referred to nephrologists at an advanced stage of the disease - CKD stage four or above. When questioned on how to optimise CKD anaemia management, three quarters (75 percent) of physicians called for increased understanding of CKD in primary care, and 82 percent called for routine eGFR (estimated glomerular filtration rate) testing, in the primary care setting in order to improve diagnosis and referrals.

“Patients in advanced stages of CKD have more related conditions such as diabetes and heart disease, significantly adding to the complexity of CKD anaemia management,” explains ERA-EDTA President, Professor Jorge B. Cannata-Andia. “Because these comorbidities reduce patients’ quality of life and overall life expectancy, there is real need to diagnose and refer patients at a much earlier stage to reduce the high burden of morbidity and mortality associated with CKD.”

CKD anaemia patients, particularly those with diabetes and heart disease, often suffer from fluctuations in their haemoglobin (Hb) levels. Maintaining stable Hb levels is a key element of effective CKD anaemia management. Nearly half (47 percent) of physicians surveyed stated that stabilising Hb levels within target range is achieved through the management of a combination of factors such as intercurrent events (kidney inflammation, bleeding, hospitalisations and infections), clinical practice patterns and use of management tools. Only 5 percent believe that the choice of erythropoietin stimulating agent (ESA) treatment alone is an important factor in maintaining Hb stability. Furthermore, results show that physicians stay well within the European Best Practice Guidelines for the Management of Anaemia (=11g/dl, not to exceed 14g/dl).1,

“It is vital that patients’ Hb levels are controlled within the target range in order to limit adverse effects,” commented Professor Francesco Locatelli, Head of Nephrology at A. Manzoni Hospital, Lecco, Italy, past President of ERA-EDTA and Chairman of the European Best Practice Guidelines. “These results support the need for flexible management, improved primary care education and CKD awareness programmes to improve diagnosis, achieve Hb stability, keep patients within the recommended range and help diminish the complexity of CKD.”

To address the growing complexity of anaemia management, the majority of physicians surveyed listed ‘flexibility of dosing frequency, such as weekly to monthly‘ (64 percent) and ‘proven safety profile in clinical practice’ (62 percent) as the top two most important factors of an ESA in effective management of CKD anaemia for physicians and their patients.

Alison Thorpe | alfa
Further information:
http://www.bm.com

More articles from Health and Medicine:

nachricht A better way to measure the stiffness of cancer cells
01.03.2017 | Duke University

nachricht Humans have three times more brown body fat
01.03.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

Im Focus: Safe glide at total engine failure with ELA-inside

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded after a glide flight with an Airbus A320 in ditching on the Hudson River. All 155 people on board were saved.

On January 15, 2009, Chesley B. Sullenberger was celebrated world-wide: after the two engines had failed due to bird strike, he and his flight crew succeeded...

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

A better way to measure the stiffness of cancer cells

01.03.2017 | Health and Medicine

Exploring the mysteries of supercooled water

01.03.2017 | Physics and Astronomy

Research team of the HAW Hamburg reanimated ancestral microbe from the depth of the earth

01.03.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>